A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

Alternate title: 
J2 - Hepatology
Secondary title: 
T2 - Hepatology
Short title: 
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
Authors: 
Cabibbo, Giuseppe
Enea, Marco
Attanasio, Massimo
Bruix, Jordi
Craxi, Antonio
Camma, Calogero
Volume: 
51
Start page: 
1274-83
Annotations: 
Type A, Priority 1
Date: 
Apr
Year: 
2010
Accession number: 
20112254
Database: 
MEDLINE RCTs
Number: 
M1 - 4
Serial: 
1527-3350
Type of work: 
M3 - Meta-Analysis
ID: 
4829
DOI: 
http://dx.doi.org/10.1002/hep.23485
Notes: 
N1 - Cabibbo G
Enea M
Attanasio M
Bruix J
Craxi A
Camma C
Key words: 
*Carcinoma, Hepatocellular/mo [Mortality]
Carcinoma, Hepatocellular/pa [Pathology]
Carcinoma, Hepatocellular/th [Therapy]
Chemoembolization, Therapeutic
Humans
*Liver Neoplasms/mo [Mortality]
Liver Neoplasms/pa [Pathology]
Liver Neoplasms/th [Therapy]
Neoplasm Staging
Publication Bias
Randomized Controlled Trials as Topic
Regression Analysis
Survival Rate
Types of evidence: 
Type A
Priorities of Care: 
Priority 1: Recognise